Development of coronary heart disease in familial hypercholesterolemia
about
Statins for children with familial hypercholesterolemiaStatins for children with familial hypercholesterolemiaStatins for children with familial hypercholesterolemiaComparison of effects of pitavastatin and atorvastatin on plasma coenzyme Q10 in heterozygous familial hypercholesterolemia: results from a crossover studyKRH-594, a new angiotensin AT1 receptor antagonist, ameliorates nephropathy and hyperlipidaemia in diabetic spontaneously hypertensive ratsDo statins reduce the incidence of stroke in familial hypercholesterolemia?Familial hypercholesterolaemia in Finland: common, rare and mild mutations of the LDL receptor and their clinical consequences. Finnish FH-group.Brachial artery low-flow-mediated constriction is increased early after coronary intervention and reduces during recovery after acute coronary syndrome: characterization of a recently described index of vascular functionFamilial hypercholesterolemia: current treatment and advances in management.Acrolein modification impairs key functional features of rat apolipoprotein E: identification of modified sites by mass spectrometry.Glycated albumin is more closely correlated with coronary artery disease than 1,5-anhydroglucitol and glycated hemoglobin A1cLong-term effect of low-density lipoprotein apheresis in patients with heterozygous familial hypercholesterolemia.Hypolipidemic treatment of heterozygous familial hypercholesterolemia: a lifelong challenge.Benefits and risks assessment of simvastatin in familial hypercholesterolaemia.Primary prevention of cardiovascular disease in childhood: recent knowledge and unanswered questions.Early lesions of atherosclerosis in childhood and youth: natural history and risk factors.The genetic basis of familial hypercholesterolemia: inheritance, linkage, and mutations.Role of colesevelam in managing heterozygous familial hypercholesterolemia in adolescents and children.A novel approach to screening for familial hypercholesterolemia in a large public venue.Heterozygous familial hypercholesterolaemia in childhood: cardiovascular risk prevention.Half a Century Tales of Familial Hypercholesterolemia (FH) in Japan.Statins for children with familial hypercholesterolemia.Initiation of PCSK9 inhibition in patients with heterozygous familial hypercholesterolaemia entering adulthood: a new design for living with a high-risk condition?Frequency of Achilles Tendon Xanthoma in Patients with Acute Coronary Syndrome.Evaluation of glycated albumin (GA) and GA/HbA1c ratio for diagnosis of diabetes and glycemic control: A comprehensive review.The effect of urbanization on the distribution of cord serum lipids in Riyadh, Saudi Arabia: a pilot study.ACAT inhibitors as antiatherosclerotic agents: compounds and mechanisms.Impacts of fresh lime juice and peel on atherosclerosis progression in an animal model.Arterial revascularization. 18-year experience with coronary artery bypass grafting in familial hypercholesterolemia.Six years of treatment with the HELP system of a patient with familial hypercholesterolemia.Treatment Patterns and Lipid Profile in Patients with Familial Hypercholesterolemia in Japan.The challenge produced by familial homozygous hypercholesterolemia when treating premature coronary arterial disease in the young.Lipoprotein metabolism in familial hypercholesterolemia: Serial assessment using a one-step ultracentrifugation method.Familial Hypercholesterolaemia Diagnosis and ManagementJapan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017Guidelines for Diagnosis and Treatment of Familial Hypercholesterolemia 2017
P2860
Q24194816-3627964C-9E2B-4F94-B604-5E4AC091ED09Q24234081-0E21CBD6-71F5-4458-9DAA-EC7FD680836EQ24243675-9161BB6C-34AF-4E40-9950-509C441D9ACBQ28254501-3946E449-6977-47AD-AF52-3A63302CD53AQ28377508-38EDCA6E-E530-4997-A42E-49AEBF61226CQ33856286-51AC7C11-044E-4391-9D18-F94658ACB799Q34390416-57918B48-B027-49BB-B2D4-97AC2CEE9F31Q34751953-6B7C19AB-2DEE-4A15-A356-6726B5672764Q34769059-0C9DDDC2-AD30-4278-A20B-DBEC54A27EBBQ35064519-740F2F5A-95EC-476E-B817-AB7BEE1CB1F7Q35101926-BD7BE8FE-D53A-409B-B39B-DC066016FCBBQ35187612-4270775F-0931-44F0-A895-706436BDB0EBQ35777404-634520D6-12CA-4063-B46F-8B194B0AEE03Q36081978-12619F0D-2544-4E52-BA50-4046D662A0CFQ36271319-5715D455-993E-49D6-8F67-960A74C8636BQ36271324-3B3C6E6B-9AC0-44E8-ACF4-35DDCAC20C05Q36925157-3B1BC2F8-D008-4A78-AF96-BA467F686AA0Q37561301-B759F80A-1F0E-4BBC-A993-C9862632ADE6Q37574714-646E6307-695F-453B-97A5-26A08F0AB64CQ37629709-3E934A68-E4E7-4ADE-BBB6-54FE9FBE2A08Q37740339-5139F618-571C-4725-B7B7-ED07001F4898Q38689931-252EF37F-188A-4154-87CE-179756B3E3ADQ38724969-AB502CC5-7B74-4AA6-BEC4-2933CE1077C6Q38751768-4A0BCAA6-EAF1-408E-A976-6FDA514245B1Q39231126-94609012-746D-4F04-B06C-5326AE76A050Q39429153-466ED3B2-C858-4E17-9414-731D1FB48AC1Q40659134-C542F852-93ED-4148-A48D-EF24D5B7AB96Q41974333-BDB8EEF2-86A0-443D-A6F9-322921D19AC9Q44039628-B63E2FA2-93D4-4D03-B397-351DDC04E677Q44073049-C713056C-7C9C-49A0-A1CF-E9DCE5FA6F4EQ49895070-3E579633-B1B6-4BC1-8488-17BF5B3A3409Q51836573-E828C56E-2897-4245-AEC4-31285AE0C096Q55055945-3FCD9396-6C6A-4FD3-A459-44391D9F18B2Q57495857-B8FC29CD-E091-40EE-8BDA-A64E347204A5Q58362346-A995A4FA-813E-4089-8091-98A300644F87Q58805700-4ACFEF1B-2712-4A16-91BA-78E9AD88451D
P2860
Development of coronary heart disease in familial hypercholesterolemia
description
1989 nî lūn-bûn
@nan
1989 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Development of coronary heart disease in familial hypercholesterolemia
@ast
Development of coronary heart disease in familial hypercholesterolemia
@en
Development of coronary heart disease in familial hypercholesterolemia
@nl
type
label
Development of coronary heart disease in familial hypercholesterolemia
@ast
Development of coronary heart disease in familial hypercholesterolemia
@en
Development of coronary heart disease in familial hypercholesterolemia
@nl
prefLabel
Development of coronary heart disease in familial hypercholesterolemia
@ast
Development of coronary heart disease in familial hypercholesterolemia
@en
Development of coronary heart disease in familial hypercholesterolemia
@nl
P2093
P356
P1433
P1476
Development of coronary heart disease in familial hypercholesterolemia
@en
P2093
P304
P356
10.1161/01.CIR.79.2.225
P407
P577
1989-02-01T00:00:00Z